Abstract. The TSH releasing activity of two new analogues of TRH 'Pyr-(N3-Im-methyl)-His-Pro-NH-(n\x=req-\ amyl)' (I) and 'Pyr-His-Pro-(tyramine)' (II) 
biological activity: 1) in vitro in superfused pituitaries and 2) in vivo after ip injection, with measurement of TSH by RIA before and after addition of each secretagogue.
Analogue I was found to be more potent than both TRH itself and Analogue II in stimulating TSH release:
at 10 nmol/l in vitro, the ratio of induced to spontaneous release was 4.13 \m=+-\0.35 Fig. 1 (Fig. 3) . Consequently, the dose-response curves and the relative potencies were assessed at this time point. However, although TRH (Azizi et al. 1974 (Brewster & Ranee 1980; Brewster et al. 1980 ). In the present study, the substitution of one of the hydrogen atoms in the proline residue by an amyl group, may have enhanced TSH release and TSH avail¬ ability in the plasma, probably by increasing resist¬ ance to enzymatic degradation. The substitution of one of the hydrogen atoms of histidine by a methyl group could also improve the stability of the molecule, as described by Vale et al. (1971 
